The way forward for Ketamine and Temper Disorders In 2019, the FDA and European Commission authorised the usage of an esketamine nasal spready under the brand name name Spravato to take care of depression. On the other hand, as of 2021, ketamine hasn't been accredited with the FDA to take https://liquid-lsd66542.articlesblogger.com/52926455/not-known-factual-statements-about-ketamine-r-isomer